Manuela Valente sells SOPH shares under 10b5-1 plan (SOPH)
Rhea-AI Filing Summary
Common shares were reported in a Form 144 filing showing a series of 10b5-1 sales by Manuela Valente. The excerpt lists four sale entries on 04/07/2026, 04/08/2026, 04/20/2026, and 05/19/2026 with per‑trade share amounts and proceeds recorded.
The filing also lists Restricted Stock Units dated 07/02/2026 under the issuer designation; other proceeds treatment and aggregate totals are not stated in the provided excerpt.
Positive
- None.
Negative
- None.
Key Figures
Key Terms
10b5-1 Sales regulatory
Form 144 regulatory
Restricted Stock Units financial
FAQ
What transactions does SOPH's Form 144 show?
The Form 144 records four 10b5-1 sales by Manuela Valente. The entries show trades on 04/07/2026, 04/08/2026, 04/20/2026, and 05/19/2026
Were these sales part of a preplanned plan for SOPH?
The filing labels the transactions as 10b5-1 sales. That label indicates they were executed under a written trading plan; the excerpt does not provide the plan text or additional terms.
Does the excerpt show proceeds or prices for the SOPH trades?
Each sale line includes a dollar amount next to the share count (e.g., 2,376 shares — 11,565.89). The excerpt presents per‑trade dollar figures but does not state whether those are gross proceeds or net amounts in the included text.